Exane Derivatives’s Cleveland-Cliffs CLF Stock Holding History

Exane Derivatives’s Portfolio CLF Stock Details CLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,042	Closed	-$12K	–	698
2020 Q1	$12K	Buy	3,042 +2,944	+3,004%	+$18.5K	﹤0.01%	421
2019 Q4	$764	Sell	98 -379	-79%	-$2.91K	﹤0.01%	567
2019 Q3	$3.44K	Hold	477	–	–	﹤0.01%	463
2019 Q2	$5.09K	Sell	477 -297	-38%	-$2.93K	﹤0.01%	473
2019 Q1	$7.73K	Sell	774 -493	-39%	-$4.93K	﹤0.01%	405
2018 Q4	$9.74K	Hold	1,267	–	–	﹤0.01%	466
2018 Q3	$16K	Buy	+1,267	New	+$13K	﹤0.01%	427

Other funds holding CLF

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Exane Derivatives's CLF Position: Q2 2020 in Review

Exane Derivatives sold out of Cleveland-Cliffs (CLF) in Q2 2020, closing a stake of 3,042 shares — an estimated $12K sold.

Exane Derivatives first reported a position in CLF in Q3 2018 and held it in 7 quarters. The position peaked at $16K in Q3 2018. 313 funds tracked by Wall St. Rank hold CLF as of Q2 2020.

Exane Derivatives reported no remaining Cleveland-Cliffs position as of Q2 2020 after selling out during the quarter.
Exane Derivatives sold 3,042 Cleveland-Cliffs shares in Q2 2020, an estimated $12K.
Exane Derivatives first reported a position in Cleveland-Cliffs in Q3 2018 and held it in 7 quarters.
Exane Derivatives's Cleveland-Cliffs position peaked at $16K in Q3 2018.
313 funds tracked by Wall St. Rank held Cleveland-Cliffs as of Q2 2020.

Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.